News from oncolytics biotech inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 06, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic Cancer

--Report More Than Doubling in One-Year Survival and Nearly Five-Fold Increase in Two-Year Survival as Compared to Historical...

Jun 15, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 9th International Conference on Oncolytic Virus Therapeutics

CALGARY, June 15, 2015 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that a series of oral and...

Jun 12, 2015, 17:00 ET

Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders

CALGARY, June 12, 2015 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) today announced the voting results from its Annual Meeting...

Jun 09, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Director Election Results from its Annual Meeting of Shareholders

CALGARY, June 9, 2015 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that all nominees listed in the management...

Jun 08, 2015, 16:00 ET

Oncolytics Biotech® Inc. Provides Update at AGM on Planned Registration Program for REOLYSIN®

CALGARY, June 8, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today provided an update...

Jun 05, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Details of 2015 Annual Meeting of Shareholders

CALGARY, June 5, 2015 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2015 Annual Meeting of Shareholders...

May 19, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Phase 1 Study in Pediatric Patients with Brain Tumors

CALGARY, May 19, 2015 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that following submission...

May 07, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces 2015 First Quarter Results

CALGARY, May 7, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced its...

May 06, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Gastric Cancer

CALGARY, May 6, 2015 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), a clinical-stage biotechnology company focused...

Apr 29, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Status from the EMA for Pancreatic Cancer

CALGARY, April 29, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), a clinical-stage biotechnology...

Apr 28, 2015, 18:22 ET

Oncolytics Biotech® Inc. Announces Extension to Regain Compliance with Nasdaq's Minimum Bid Price Rule

CALGARY, April 28, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ:ONCY) announced today...

Apr 20, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 2015 AACR Annual Meeting

CALGARY, April 20, 2015 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that a series of poster...

Apr 17, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Malignant Gliomas

CALGARY, April 17, 2015 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), a clinical-stage biotechnology company...

Apr 15, 2015, 06:30 ET

Oncolytics Biotech® Inc. Presents at UK Immuno-oncology Meeting

CALGARY, April 15, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr. Matt...

Apr 13, 2015, 06:30 ET

Media Advisory - Oncolytics Biotech® Inc. to Participate in the 14th Annual Needham Healthcare Conference

CALGARY, April 13, 2015 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will participate...

Apr 07, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Gastric Cancer

CALGARY, April 7, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that it has...

Mar 26, 2015, 06:30 ET

Oncolytics Biotech® Inc. Presents at the 2015 Immune Checkpoint Inhibitors Meeting

CALGARY, March 26, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr. Giovanni...

Mar 25, 2015, 06:30 ET

Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Status from the EMA for Ovarian Cancer

CALGARY, March 25, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), a clinical-stage biotechnology...

Mar 16, 2015, 18:08 ET

Oncolytics Biotech® Inc. Announces 2014 Year End Results

CALGARY, March 16, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced...

Mar 05, 2015, 06:30 ET

Oncolytics Biotech® Inc. Collaborators Present Preclinical Data on the Combination of REOLYSIN® and Radiotherapy in Melanoma at the Irish Association for Cancer Research Conference

CALGARY, March 5, 2015 /PRNewswire/ - Oncolytics Biotech® Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that an oral...